Evidence map›Paper›PMID 22682028›Full record

ReviewFertility and sterility2012

The next (re)generation of ovarian biology and fertility in women: is current science tomorrow's practice?

Dori C Woods, Jonathan L Tilly

Open access · greenAbstract readReview
In one paragraph

Review in Fertility and sterility, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Human reproduction open · 2020
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  18. Review
  19. Review
  20. Perspective in infertility: the ovarian stem cells.Journal of ovarian research · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dori C WoodsVincent Center for Reproductive Biology, Massachusetts General Hospital Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts 02114-2622, USA. dwoods2@partners.org
Jonathan L Tilly
Massachusetts General Hospital · USSt Vincent Hospital · US

Funding

Origins/Functions of Mammalian Female Germline Stem CellR37AG012279 · NIA · NORTHEASTERN UNIVERSITY · PI TILLY, JONATHAN LEE · 2006 to 2015
$3.3M
Stem cell derived ovarian somatic cells in ovarian replacement therapyF32AG034809 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI WOODS, DORI COUSINS · 2009 to 2011
$157k
NIA NIH HHS F32 AG034809NIA NIH HHS F32-AG034809NIA NIH HHS R37 AG012279NIA NIH HHS R37-AG012279
6 · The paper itself

Abstract

Stem cell-based strategies for ovarian regeneration and oocyte production have been proposed as future clinical therapies for treating infertility in women. However, utilization of embryonic stem cells or induced pluripotent stem cells to produce oocytes has had limited success in vitro. A recent report of the isolation and characterization of endogenous oocyte-producing or oogonial stem cells (OSCs) from ovaries of reproductive age women describes the first stable and pure human female germ cell culture model in which a subset of cells appear to initiate and complete meiosis. In addition, purified human OSCs introduced into adult human ovarian cortical tissue generate oocytes that arrest at the diplotene stage of meiosis and successfully recruit granulosa cells to form new primordial follicles. This overview examines the current landscape of in vitro and in vivo gametogenesis from stem cells, with emphasis on generation of human oocytes. Future research objectives for this area of work, as well as potential clinical applications involving the use of human OSCs, are discussed.

Indexed as

AdultBiomedical ResearchCell BiologyFemaleFertilityHumansModels, BiologicalOvaryProfessional PracticeRegenerationRegenerative MedicineReproductive MedicineScience

Identifiers

PMID22682028
PMCPMC4270270
OpenAlexW2023277103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.